News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

RxElite Subsidiary FineTech Pharmaceutical, Ltd. President, Speaker at EBRD Panel on "High Tech -- High Stakes" for European Emerging Growth Countries in the Global Marketplace


6/9/2008 10:44:10 AM

MERIDIAN, ID--(Marketwire - June 09, 2008) - RxElite, Inc. (OTCBB: RXEI), a developer, manufacturer, and marketer of specialty generic prescription drug products, was honored that Dr. Arie Gutman, a board member and President of its FineTech subsidiary, had been selected as a participant in a panel discussion attended by more than a hundred bankers, entrepreneurs and investors from Eastern Europe at this year's annual meeting of the European Bank for Reconstruction and Development (EBRD).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES